AACR Cancer Progress Report Reveals 33 Percent Decrease in Cancer Death Rate, 1990 to 2020
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Sept. 13, 2023 -- The age-adjusted overall cancer death rate in the United States decreased by 33 percent from 1991 to 2020, according to the annual AACR Cancer Progress Report 2023 published online Sept. 13 by the American Association for Cancer Research. The annual report provides the latest statistics on cancer etiology, mortality, and survivorship, as well as updates and context regarding the latest research in cancer.
According to the report, 14 new anticancer therapeutics were approved by the U.S. Food and Drug Administration during Aug. 1, 2022, to July 31, 2023, including a new gene therapy-based immunotherapeutic for bladder cancer, a first-in-class antibody drug conjugate for ovarian cancer, and four new T-cell engaging bispecific antibodies for hematologic malignancies. In addition, two new imaging agents were approved and the use of 12 previously approved anticancer therapeutics were expanded. Between 1991 and 2020, the age-adjusted overall cancer death rate in the United States decreased by 33 percent, resulting in an estimated 3.8 million cancer deaths averted due in large part to advances in prevention, early detection, and treatment. A 43 percent decline was seen in breast cancer mortality between 1989 and 2020, and the decrease in lung cancer mortality accelerated by 0.9 percent per year between 1995 and 2005 to nearly 5 percent per year between 2014 and 2020.
"It is our hope that this comprehensive resource will help to increase knowledge about the myriad diseases we call cancer as well as the innovative research that is improving and extending lives," Margaret Foti, Ph.D., M.D., the chief executive officer of the American Association for Cancer Research, said in a statement.
AACR Cancer Progress Report 2023
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Vaginal Cancer Incidence Increasing Globally
WEDNESDAY, July 3, 2024 -- The incidence of vaginal cancer is increasing globally, according to a study published online June 25 in BJOG: An International Journal of Obstetrics...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.